The Medical Science Liaison: An A to Z Guide, Second Edition by Albert, Erin & Sass, Cathleen
Butler University 
Digital Commons @ Butler University 
Butler University Books 
7-22-2011 
The Medical Science Liaison: An A to Z Guide, Second Edition 
Erin Albert 
Butler University, ealbert@butler.edu 
Cathleen Sass 
Follow this and additional works at: https://digitalcommons.butler.edu/butlerbooks 
Recommended Citation 
Albert, Erin and Sass, Cathleen, "The Medical Science Liaison: An A to Z Guide, Second Edition" (2011). 
Butler University Books. 10. 
https://digitalcommons.butler.edu/butlerbooks/10 
This Book is brought to you for free and open access by Digital Commons @ Butler University. It has been accepted 
for inclusion in Butler University Books by an authorized administrator of Digital Commons @ Butler University. For 
more information, please contact digitalscholarship@butler.edu. 

The Medical Science Liaison:
An A to Z Guide
Second Edition
A book by
ERIN ALBERT WITH CATHLEEN SASS
© 2011 Erin Albert. All rights reserved.
No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, 
mechanical, photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United  States 
Copyright Act, without the prior written permission of the CEO of Pharm, LLC.
Limit  of Liability/Disclaimer of Warranty: While the publisher and author have used their  best  efforts in preparing  this book, they make no 
representations or  warranties with respect to the accuracy or completeness of the contents of this  book and specifically disclaim any 
implied warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives 
or  written sales materials. The advice and strategies contained herein may not  be suitable for your situation. You should consult with a 
professional where appropriate. Neither the publisher nor author shall be liable for any loss of profit  or  any other commercial damages, 
including but not limited to special, incidental, consequential, or other damages. The information contained herein is not necessarily the 
opinion of the author or publisher.
Designations used by companies to distinguish their products are often  claimed by trademarks. In all instances where the author or 
publisher is  aware of a claim, the trademarks have been noted where applicable. The inclusion of a trademark does not imply an 
endorsement or judgment of a product or service of  another company, nor does it imply an endorsement or  judgment by another company 
of this book or the opinions contained herein.
First published by AuthorHouse, Bloomington, IN, 2007. First edition ISBN: 978-1-4343-3750-4
Second Edition ISBN: 978-1-4566-0430-1
Published in eBook format by eBookIt.com
http://www.eBookIt.com
To my mom, Dorothy, dad, John, and brother, Mark -
for always reminding me that life is not a dress rehearsal
—Erin
In Memory of Mac Williamson
—Cathy
Table of Contents
Introduction: The History of the MSL
The Past and Future of MSLs: Interview with Stan Bernard, MD, MBA
History
PART I: BECOMING A MSL
Chapter 1: What is a MSL?
The Challenges of a MSL
The Real World: An Interview with a Working MSL - Ernie Pitting, RPh, MS, PharmD candidate
Chapter 2: Activities, Salary, Job Satisfaction and Career Paths of the MSL
Benefits for the MSL: Interview with Chris Conley, CSAM
Chapter 3: Getting Hired
Part 1: Values Assessment
Skills and abilities specific to the MSL:
Part 2: Resume/CV
Part 3: The Cover Letter
Contacts/Networking Strategies
Getting Into the MSL Role: A Recruiter’s Perspective - Interview with Tony Beachler
PART II: PERFECTING THE ART OF LIAISING
Chapter 4: Starting off as a MSL
Miscellaneous for the New MSL
Erin’s List of Over 20 places to find Thought Leaders
Regulatory Compliance
Legal/Regulatory Issues for the MSL To Consider: Interview with Christopher R. Hall, Esq.
The International MSL Perspective: Interview with Michael Hamann, PhD
Chapter 5: Customers’ Viewpoints
Interview with Chris Bojrab, MD
Interview with Ron Chervin, MD, MS
Interview with James A. Simon, MD, CCD, FACOG
Interview with Paul Keck, MD
Chapter 6: Research & Technology
Resources For the MSL: An Interview with LouAnn Fare, MS
Managing Medical Information: An Interview with Dr. Amy Peak
MSLs, Metrics and Technology
About Metrics: An Interview with Michael Taylor
Chapter 7: Work + Life = Balance?
Erin’s Wall of Fame
The MSL Father - Tim Hill, PharmD, MS
Working as a MSL/Mom: Interview with Carole Carter-Olkowski
Working Solo - It’s Really A Team Effort
PART III: POST MSL - WHAT’S NEXT?
Chapter 8: Job Hopping
The MSL Moving Onward: Interview with Bryan Vaughn
Over 30 Things To Have Experienced By Your 5th Year as a MSL:
Chapter 9: Management of MSLs
Medical Science Liaison Outsourcing: Interview with Kyle Kennedy
Interview with a MSL Manager: Susan E. Malecha, PharmD, MBA
Chapter 10: The Afterlife
Other career alternatives for MSLs:
Academic Pharmacy After the MSL role: Interview with Scott Stolte, PharmD
Entrepreneurialism Post MSL: Interview with Jane Chin, PhD
Ten Transferable Skills From MSL to Entrepreneur:
Life After the MSL Role in Medical Education: Interview with Matt Lewis, MPA
Chapter 11: The Future of the MSL Role
The Clinical Trial Liaison: Interview with Brian Best
Future Of The MSL: Closing Interview with Dr. Stan Bernard
In Conclusion
Appendix A: Major Medical Associations/Meetings for Therapeutic Areas
Appendix B: Real World Career Paths to and Beyond the MSL
Appendix C: Acronyms & Abbreviations
Bibliography, References, and Resources
Acknowledgements
PART IV: SECOND EDITION NEW MATERIAL
Epilogue (Second Edition Bonus Material)
New Interviews: What is Beyond the MSL Role?
Anonymous
Charles Arena, MD Medical Director, Utah Clinical Trials, LLC
Tom Peddicord, PharmD, FCCP Account Group Director, Global Prairie
Updates Since the First Edition
Other Books By Dr. Erin Albert
Introduction: The History of the MSL
Many know that  the origin of the Medical Science Liaison (MSL) came out  of Upjohn. What is not  largely 
known, however, is the drug that  started the MSL movement: it  was tolbutamide (Orinase®). According to the 
text, A Century of Caring: The Upjohn Story by Robert  Carlisle, the first ever MSL program was initiated by 
marketing to establish rapport  and provide educational awareness to doctors before they were able to write 
prescriptions, during medical school. In 1967, the program was started and seeded by sales professionals that had, 
“intense interest in science, [had] high social skills, and recognize[d] that  they [were] no longer detailing 
products”.1
The MSLs began calling on medical schools and thus, a movement was born. Upjohn had been mostly unknown 
to medical students, but  after just 6 years of the MSL program, “Upjohn was one of the best-known”1 companies 
to medical students. The entire onus of the MSL was to provide education in the form of monographs, access to 
internal researchers, and assistance for external educational programs. The program was conceptualized and 
developed a mission to provide appropriate use of oral diabetic drugs, which at the time was a novel approach to 
diabetes.1
Today, there are thousands of MSLs across the country, in hundreds of disease states and therapeutic areas. As will 
be explored further in this book, MSL job descriptions, professional backgrounds, and job motivators can vary 
widely from company to company. This text will discuss who the MSL is, what  the MSL does, and where the role 
might  be headed in the future. The approach we are taking with the book is to look at the product life cycle of the 
MSL, so to speak. We begin with a professional with a long history in the world of pharmaceuticals, Dr. Stan 
Bernard. We not  only ask him about  the past history of the MSL world, but we also explore his ideas on what the 
future may hold for the profession at the end of this book.
The Past and Future of MSLs: Interview with Stan Bernard, MD, MBA
Stan Bernard, MD, MBA is President of Bernard Associates (www.BernardAssociatesLLC.com), a pharmaceutical 
and health care industry management consulting firm offering strategic planning, marketing, medical marketing, 
competitive simulations/planning, and business development services. Dr. Bernard is nationally-recognized as a 
consultant, speaker, and author. He has published over 50 book chapters and articles on pharmaceutical and 
health care topics. Dr. Bernard is a former Senior Fellow at The Wharton School of Business where he initiated 
and taught in the “Pharmaceutical Management” course for fourteen years.
Previously, Dr. Bernard served as a Consulting Principal at A.T. Kearney and held several executive positions at 
Bristol-Myers Squibb Pharmaceutical Company. He served as U.S. Product Manager for the launch of the 
cholesterol-lowering drug Pravachol®, Bristol-Myers Squibb’s most successful pharmaceutical product. He 
served as Associate Medical Director, where he co-founded the first doctor-only Medical Science Liaison (MSL) 
group in the U.S.. Dr. Bernard also served as U.S. Managed Care Medical Director, the first person to hold such a 
position in the pharmaceutical industry, and as U.S. Director-Pharmacoeconomics. He also worked in Worldwide 
Business Development and U.S. Medical Operations. Dr. Bernard received his M.B.A. in marketing and health 
care management from the Wharton School of Business. He received his Medical Degree from Baylor College of 
Medicine. Dr. Bernard can be reached via email at: SBernardMD@BernardAssociatesLLC.com and via phone at: 
(908) 234-2704.
History
As you know, Upjohn started the MSL function in the late 1960’s. However, the first MSLs came from sales. 
Subsequently, other programs moved to professionals with a science background.2 Can you share your experience 
on what generated that switch, and how the scientist MSL began?
In 1988, Jan Leschly was the President  of E.R. Squibb. A pharmacist by training and an experienced businessman, 
Jan believed that individuals with combined backgrounds in business and science would represent the next wave 
of professionals in the pharmaceutical industry and provide Squibb with a competitive advantage. Toward this 
end, Jan envisioned a sales force composed exclusively of business-oriented doctors.
In 1989, Squibb hired David Best, an MD/MBA from the advertising industry, to turn Jan’s vision into reality. 
David recruited me from Squibb’s Worldwide Division to help him create and implement the first  doctor-only, 
regionally-based field force. Together we hired, trained, and managed a total of 12 doctors, predominantly 
physicians. We called this concept “Medical Services Managers” or MSMs to distinguish it  from competitors’ 
medical science liaisons (“MSLs”). At that time, MSLs were typically top sales representatives without advanced 
scientific degrees who called on doctors to communicate scientific information and address more complex 
product questions.
From the outset, MSMs were designed to be different  from MSLs and other sales representatives. As doctors, 
MSMs could relate to and interact with key opinion leaders and other doctors as “peers”. They shared a 
comparable level of scientific training, experiences, and knowledge with their physician customers. This enabled 
MSMs to earn the respect  and time of physicians. In fact, BMS marketers found that  MSMs were spending 
dramatically more time with physicians than sales representatives.
The roles of MSMs also differed dramatically from those of MSLs. We trained MSMs to handle several novel 
tasks, such as the management of regional and local opinion leaders, including speaker training; identification and 
placement of Phase IIIB and IV clinical trials; facilitation of physician dinner meetings; spearheading the pre-
launch of new products; and training of sales representatives on disease states and product information. Like a 
special military force, the roles of MSMs expanded over time as senior Bristol-Myers Squibb (“BMS”) executives 
recognized their extensive capabilities and impact.
It  was not long before competitors took notice and began to develop their own versions of the MSM program. The 
MSM program became the foundation for a number of regionally-based, scientifically-trained medical 
professional programs across the industry. Probably the most satisfying aspect for me is the number of “MSM 
Alumni” who have ‘graduated’ from the program and moved on to executive leadership roles in other companies. 
While the MSM name has changed back to MSL, the concept of MSLs with scientific training and advanced 
degrees endures.
Has the MSL changed in terms of work since the first science based MSL teams vs. today?
I think there have been dramatic changes in the roles of science-based MSLs reflecting industry-wide changes. 
The most significant changes have been regulatory: stricter regulations on pharmaceutical product  promotion have 
virtually eliminated the MSL placement of clinical trials and grants and the facilitation of dinner meetings, for 
example. Therefore, these MSL roles have been reduced in order to comply with those regulations.
Conversely, three other industry factors have changed to enhance the roles of the MSL: the decreasing numbers 
and importance of the sales representatives; the increasing complexity of science; and increasing pharmaceutical 
competition. The declining role and impact of the sales representative means that the MSL interaction and 
communications with physicians and other stakeholders are more important. The complexity of science has 
resulted in a greater need for scientifically-educated MSLs to help translate these new technologies and 
discoveries. New biologicals and biotechnologies, complicated biochemical pathways, targeted therapies, drug 
safety, and pharmacogenomics are all critical areas that pharmaceutical stakeholders need to understand.
Competition between companies and among products has intensified over the years. Most major pharmaceutical 
companies need to have a strong MSL group just  to be competitive. There is now greater product competition 
with more in-class and across-class therapeutic agents, generics, over the counter medications (OTCs), and 
alternative therapies. Because of increasing limitations on promotions, MSLs are playing a larger role in the 
overall promotional mix for product marketers.
Dr. Bernard’s comments on the future of the MSL are contained in the final chapter of this book.
PART I: BECOMING A MSL
Chapter 1: What is a MSL?
Outside of those performing the job, very few understand the role, activities, or functions of the Medical Science 
Liaison. How the MSL role is defined and their activities vary widely from company to company. Generally 
speaking, a MSL is a field-based scientific professional that  works for a pharmaceutical, biotechnology, medical 
device, or managed care company. The primary responsibility of the MSL is to establish, develop, and foster 
collaborative relationships between thought  leaders and the companies they represent  via the advancement of 
science and medicine. Ideally, companies have MSL teams report through the medical affairs department.
In terms of professional background, most MSLs are pharmacists (60-70%), with the majority having a doctorate 
of pharmacy degree (PharmD). Approximately 10% are PhDs, and 1-2% are MDs or DOs. The remainder of 
MSLs consists of nurses, or professionals with some type of medical, scientific, or business backgrounds.3
MSLs interact with a variety of healthcare professionals. At  many companies, the primary contacts or customers 
of the MSL are academic thought  leaders. Academic thought leaders are typically physicians or other healthcare 
professionals that perform research, publish, and/or teach within an area of expertise. National and international 
thought  leaders often collaborate outside their own home organization in areas of research, publishing, and 
education. Another customer or contact  of the MSL may be the academic institution itself. Many institutions host 
continuing medical education conferences and need resources for hosting such events. The MSL can assist the 
institution in finding support for such academic endeavors.
In addition, the MSL may call upon other professionals such as nonacademic physicians, pharmacists, nurses, 
other allied healthcare professionals or medical education providers. MSLs may also support patient advocacy 
associations. Examples of such groups include: The American Heart  Association, the Cystic Fibrosis Foundation, 
or The Arthritis Foundation. Many patient  advocacy groups also provide educational tools for patients and 
healthcare professionals regarding the disease states. Finally, MSLs may work with managed care organizations to 
provide clinical trial information and data for formulary decisions when requested by medical decision makers 
within the managed care organization.
One of the most common questions asked of the MSL is how they differ from a pharmaceutical sales 
representative. A sales representative provides samples to physicians. Representatives also sell a product  based 
upon integration of key brand messages and appropriate use of a product based upon the package labeling. 
Typically representatives work primarily with doctors who provide direct patient  care. The sales representative’s 
goals are often based upon their personal and regional sales performance of a drug or portfolio of drugs that  they 
promote. The representative is limited to information included in the approved and current package insert (PI, also 
known as the product label).
In contrast, the MSL provides medical information, fair balanced scientific exchange, and discusses disease states 
and all therapeutic options. Since MSLs are scientists, the exchange of data and information is peer-to-peer 
education and information sharing, rather than selling or marketing. The MSL works within scientific education 
and research realms. While the primary customer of a sales representative is a clinically based physician, the 
MSL also works with scientists that perform research and teach. MSLs may also work heavily with pre-clinical 
researchers, who are in some cases are PhDs. The MSL’s performance and goals are usually based upon 
outcomes, often involving long-range objectives. MSLs do not provide samples, are rarely measured by call 
frequency and never measured on sales data.
There are 5 basic elements to the MSL role. Each of the 5 elements varies from company to company and between 
therapeutic areas. The five elements are: research, scholarship (learning), education (teaching), service, and 
networking (see Figure 1). The five elements are very similar to academic roles and responsibilities. Due to the 
fact that the roles of MSLs and academics are similar, many MSLs come from academia.
Research. One of the primary functions of a MSL is to foster and champion research ideas and proposals through 
a company. The MSL literally acts as a ‘liaison’ between the pharmaceutical company they are employed by and 
the academic institutions or researcher. Innovation in any field requires constant research and development. 
Companies seek opportunities to improve the lives of patients and expand product uses through research. 
Research opportunities are varied and include: investigator-initiated research (prospective or retrospective), 
identification of investigators interested in participating in company sponsored research, or linking of potential 
researchers with a shared interest.
Investigator-initiated research (IIR) can be proposed in several ways. Data sets already accumulated preclinically 
or clinically can be reviewed for new research ideas, or what more commonly is known as retrospective analysis. 
This data has already been collected either in cells, animals, healthy human volunteers, or patients, and 
researchers propose to go back and review the data to answer new research questions or do subset  analysis. IIR 
may also consist of prospective preclinical or clinical trials where the research is yet to be performed. Some 
researchers focus on preclinical aspects of therapeutic research, others focus on clinical or patient focused 
research, and some perform both types of research.
Company sponsored research protocols often require identification of investigators. This is another function of the 
MSL at many companies. Typically, companies sponsor phase I-IV trials for compounds, and need external 
investigators to provide patients and expertise for clinical trials. Some clinicians only work in clinical research. 
Other physicians have private practices or university based practices and also perform research on top of their 
clinical practices. It  is the responsibility of the MSL to work in tandem with the clinical research departments to 
fully understand what  the company’s needs are for investigators and match those to the physicians performing 
research within their geographic assignment or territory. Many clinical research departments put  together 
questionnaires or site visit  feasibility forms for the MSL to utilize. The MSL may either visit  the site to obtain the 
information, or the MSL may provide the feasibility forms directly to the sites they feel might  meet the criteria for 
a particular study.
Many MSLs have conducted research in the past, particularly if they came from a previous industry or academic 
setting. In many cases, MSLs have been trained to understand good clinical practices (GCPs) as well as quality 
research design and proper statistical analysis of clinical research data. Some companies will allow MSLs to co-
author papers on original research, and allow for collaborative research and development  for all parties involved 
in a research concept. While co-authorship is somewhat  controversial, the point  that collaborative research and 
exploration of new ideas and concepts for improving the lives of patients remains the primary focus and driver for 
all that the MSL does within the domain of research.
In an industry wide survey of MSLs, investigator-initiated trial work was the most rewarding facet of the MSL 
role in terms of personal job satisfaction, over other areas of responsibility for the MSL.3 The intrigue of original 
ideas and study of research concepts is one of the most rewarding aspects of the MSL role. The amount of time a 
MSL performs in the area of research will be dependent upon the company, the MSL role itself, and the product 
lifecycle(s). Newer products tend to have more research questions remaining, which would lend to more 
investigator-initiated research or Phase IIIB/Phase IV company sponsored research. A product  on the market  for 
several years usually has fewer remaining research questions.
Scholarship (Learning). One of the best  facets of the MSL job is on the job education. MSLs must  keep abreast 
of cutting edge research and innovation within the therapeutic areas they cover. Therefore, it is imperative that 
MSLs are life long learners. For those that love education and school, the MSL role is excellent for learning about 
the latest  innovations in science. Intellectual challenge is one of the key drivers for the MSL to have high job 
satisfaction.3
One of the central responsibilities for MSLs is to attend medical meetings and symposia on a local, regional, 
national, and international level in order to learn about new data and hear what  researchers are developing. One 
therapeutic area of coverage alone could encompass several hundred medical and professional meetings in a year. 
Since the MSL has technical acumen, they are often the reporters of information from these medical meetings 
back into the companies, whether it is explicit  scientific data gathered at  professional meetings, or competitive 
intelligence gathered in the field. MSLs often attend major medical meetings around their respective therapeutic 
areas (for example, a MSL in the cardiovascular therapeutic area may attend the American College of 
Cardiology’s Annual Meeting). A listing of major medical meetings and organizations for different  therapeutic 
areas is provided in Appendix A.
There are several industry wide MSL specific meetings that are not  therapeutic area specific (Table 1). The 
majority of MSLs are pharmacists. Therefore, a table is included of major pharmacy meetings of interest  to the 
MSL (Table 2).
Several of the professional organizations listed also have special interest groups or smaller subsets of medical 
affairs or MSL groups within the larger organization. Those include the American College of Clinical Pharmacy 
(ACCP), which has an industry special interest group/listserv. DIA has a special interest group for medical 
communication professionals (the Medical Communications Special Interest Area Communities or SIACs). The 
Healthcare Business Women’s Association contains local or regional chapters for women in specific geographical 
locations, including Boston, Indiana, Research Triangle Park, NJ/NY, and others. Many of these organizations 
have not  only large annual meetings, but  also they host many smaller special interest or smaller geographic 
meetings, and can be great way to network within the industry.
Education (Teaching). One of the biggest opportunities for MSLs is the ability to share their technical 
knowledge. Peer-to-peer sharing of information is the foundation of education for the MSL, and is one of the 
major facets of the role. Many MSLs have come from an academic position (most likely a college of pharmacy), 
but many come from varied educational roles within and outside the pharmaceutical industry. After a clinical or 
academic pharmacy position, many move to medical information groups at  pharmaceutical companies, and then 
into the MSL role. Regardless of formal education, most  MSLs share a thirst  for sharing knowledge and 
information.
The educational component  is somewhat dependent upon product lifecycle as well. For example, a MSL working 
on a new product may be doing more formal education, such as presentations to managed care formulary experts, 
or clinicians that are not  familiar with the clinical research behind a new compound. A MSL covering an older 
product  may focus less on the basic common information on a compound (absorption, distribution, metabolism 
and excretion or ADME, pharmacokinetics or PK, drug-drug interactions, etc.) and focus more on preclinical or 
clinical research that  explores possible line extensions of a compound or new indications. While the type of 
education may change with the product lifecycle, the fact remains that MSLs are educators.
The MSL can also educate internal colleagues at  the companies they serve. MSLs are savvy and know what the 
positions are from many thought leaders on a particular disease state or therapeutic area and can educate on the 
state of the minds of these thought leaders regarding therapeutics back to the company. This in turn can assist 
directions for research ideas and collaborations among researchers, clinicians, and pharmaceutical companies. 
MSLs also attend various major medical meetings (i.e., American Psychiatric Association, The North American 
Menopause Society Annual Meeting) and can report back to their respective organizations competitive 
intelligence on potential or competitive products, or provide overviews of the conferences in general to those in 
the company that were unable to attend the meetings.
Service. Another major component  of the MSL’s work is that of service. The MSL serves many customers. The 
first  customer of the MSL is the academic thought  leader. However, there are many other customers of the MSL, 
including, but not  limited to: internal customers (medical affairs, clinical operations, marketing, sales, medical 
information, competitive intelligence, drug discovery, pharmacovigilance, epidemiology, etc.), external customers 
(medical organizations and advocacy groups, professional societies, educators, allied healthcare professionals, and 
managed care organizations). One of the key components to the MSL functioning well is to fully understand the 
spectrum of their customers, who they serve, and how to prioritize requests. Whether the MSL is providing a 
customer with medical or clinical information, collaborating on research ideas or concepts, or sharing external 
information, the MSL always has challenges in managing multiple customers with multiple projects. The 
customer mix, both internally and externally, will depend upon several factors: the product’s lifecycle, the 
therapeutic area(s), the size and structure of the company the MSL works for, and the structure of organizations 
and academic centers within the MSL’s geographical assignment.
Networking. Whether or not  the MSL is fully aware of it, networking is also a key component  to the MSL job. 
MSLs are connectors. They connect  themselves to others, both internally and externally, and link others together 
where appropriate. They connect  to thought leaders, to ancillary staff at  institutions, to professional societies, and 
to patient advocacy groups. They connect  the company to various customers in their geographic assignment. They 
connect thought  leaders to each other, sharing research concepts and potential collaborations between researchers, 
in ways that perhaps even the researchers never thought of before. In many academic institutions, pre-clinical 
research and clinical research can be disconnected, which is an opportunity for the MSL to cross pollinate, share 
ideas, and link up potential collaborators. In essence, the MSL is a living, breathing professional networker. MSLs 
also must connect ideas. One of the skills of an advanced MSL is the ability to think across therapeutic areas, 
research concepts, researchers, and the companies they represent  to come up with scientific innovations and 
methods of connecting professionals to each other. Referral networking can provide an element  of job satisfaction 
and keep the job interesting.
The Challenges of a MSL
The MSL job, just  like any other, is not always easy and perfect. There are challenges, frustrations, and issues 
with the role. In this section, a few of the big issues surrounding the MSL will be discussed and a few tips and 
tricks on how to handle these issues will be provided. Other chapters within this book will help with other 
frustrating areas for the MSL as well.
Damage  Control. There is nothing worse than starting out with a new company as a MSL and having the former 
MSL sabotage your territory before you even step into it. Almost as frustrating is working with a thought  leader to 
submit  a protocol idea as an investigator initiated trial or IIT only to have it shot down, or the company has 
changed its mind during the development of the idea. However, this happens, and it  is best  managed by damage 
control. This consists of apologizing for what happened in the past (as it  was out of your control), committing to 
trying to ensure it doesn’t  happen again in the future, and under promising and over delivering. The cardinal rule 
of a MSL is to commit  to nothing except  exploration of possibilities and commit to only what you know you can 
deliver. Promise nothing beyond this and you will be able to successfully manage your customers’ expectations.
Metrics. The bane of the MSLs’ existence can sometimes be metrics. What the MSLs do is form long-term 
relationships between the company and the thought leader community. How does a MSL manager quantify the 
quality of these interactions? How can you benchmark good versus bad work from a MSL? Often, some 
companies apply the reach and frequency model to their MSL teams hoping that quantity rather than quality 
metrics are a clear cut, decisive measurement of MSL effectiveness. However, companies that place firm numbers 
of calls on their MSLs oftentimes alienate the MSL and waste the time of the thought leaders, and run the risk of 
lowered quality. A combination of quality and quantity metrics can be utilized. MSLs work in a gray zone. The 
manager that understands this and can in turn articulate the long term value of a MSL team to higher management 
of an organization will be able to keep their teams in place. If a MSL manager doesn’t fully realize the qualitative 
value of their MSLs teams, the team is doomed before it starts.
Inefficiencies. This and the following section go hand in hand. The adage, “hurry up and wait” applies to the 
MSL role. As a MSL, there are times that a thought  leader will cancel on you last  minute, or keep you waiting for 
hours. The best way to manage this time issue is to make the most of your down time. Make sure you always have 
work to do. Log your calls or write up your reports while you are waiting rather than postponing it  until the end of 
the week to write your notes. If you delay, you also run the risk of forgetting half of the content of the 
conversation. Be prepared to have a plan B, and even a plan C. Try to ensure you are going to a place where you 
have more than one appointment scheduled, so your entire day is not lost if one person cancels.
Planes, Trains, and Automobiles. MSLs travel, frequently and inconsistently. Travel is not  what  it  used to be. 
Airlines are notoriously late and frankly do not always care whether or not  you make your appointment  or 
connecting flight on time. A MSL will miss flights, or spend countless hours (sometimes overnight) in airports 
waiting for flights to get home or get  to the next appointment. You will also travel long distances only to have 
your appointment cancelled. When you are looking at  a potential MSL position, human resources (HR) should be 
questioned about their travel policies. What type of travel help desk/support do they have in place for the MSL? 
Do you receive a company car or a stipend for your mileage? Does your potential company offer the MSL a flight 
club room membership? (Which can be a lifesaver when the airline cancels your flight  and you need a quiet 
respite to complete your work.) If you are happier to have a territory where you drive most of the time, consider 
items like global positioning systems (GPS), satellite radio, a cell phone car charger, and books on CD.
One of your most  valuable items when you are a MSL is your library card. Keep a collection of books on CD in 
your car ready for a 3-hour one-way trip before appointments. If you can blend learning with travel, you 
maximize your efficiency while on the road. Many companies offer training sessions on CD for this purpose. 
Also, if you can keep your frequent  user points with one or two airlines and hotel chains rather than splitting them 
among all the providers, you will have more clout with one (and more points) over the long haul.
Remote (lack of) Control. One of the biggest concerns often heard from MSLs is the loneliness of the job. New 
MSLs often stepped from a social office environment into the work-alone-from-home environment. Some people 
never get  used to this alienated feeling and discontinue their work as a MSL because of the solitude of the job. 
The best remedy for this problem is to pick up the phone and call your colleagues. Seek mentors. Find someone 
within the group that has a lot  of experience and ask for help or ideas when you need them. Everyone is better at 
something. What  can you learn from each and every person you encounter? This also includes your thought 
leaders. Like other professionals, thought leaders are the best at what they do in a certain area and they like to 
teach, so ask a lot of questions and learn from them.
Paperwork. The pharmaceutical industry is one of the most regulated industries in the world. PhD bench 
scientists keep scientific notebooks. PharmDs have to keep records of prescriptions being filled. MDs have charts 
for their patients. Documentation for the MSL is a must; there is no way around it. Manage it. Fill out your forms 
and reports as quickly as possible. Find a best way for you to stay organized and be regular about your reporting. 
It  is important  to record expenses after each trip. Submit  expense reports with frequency and regularity. Get into 
the habit of doing paperwork in a timely fashion. Your manager will thank you, and you will thank yourself in the 
long run. Also, it is important  to schedule regular, reoccurring times during the week to be in the office. Office 
time is just as important  as field time for the MSL. A MSL that  is in the field 5 days a week will struggle to find 
time to file their paperwork and keep up with their reading, unless they enjoy working on weekends, which can 
lead to burnout.
Job Security. MSLs, in general, feel that  their jobs are not  secure. In our annual MSL job satisfaction survey, job 
security was one of the higher areas of concern to MSLs versus the general population utilizing a model of 
Hertzberg’s theory of job satisfaction.3,4 With globalization, unanticipated Food & Drug Administration (FDA) 
rulings, and the unpredictability of research outcomes, the one thing a MSL can count  on in this job is change. 
The best  way to manage this issue is to be flexible, become the best  at  what you do, and not  fear or resist change. 
Nothing is guaranteed in life, but  if you can make yourself an expert in a specific area of the MSL role, or if you 
can go above and beyond your job description, smart managers and smart companies will bend over backward to 
keep you.
Change Management. As mentioned in the last  paragraph, change is inevitable as a MSL. The industry is 
dynamic. If you like science, business, and change, the MSL role could be a great one for you. Ask yourself what 
new trends you are interested in learning more about and how they can fit  into your current role. Seek better or 
more efficient ways to improve your work. Try new ideas and concepts out and share them with your colleagues. 
The best way to manage change is to embrace it and be as flexible as possible.
Moving on  Up, or Over. The most  frustrating item for a seasoned MSL is where to go from the MSL role. Many 
MSLs feel they are caught in a “career cul-de-sac” and can’t  get  out of it. Perks like working from home, a 
company car, and autonomy are very seductive. If you feel you are stuck in this situation, realize that every job 
has plusses and minuses. Can you improve your current situation by taking on extra projects? Can you further 
your professional coursework? Are you fully utilizing the tuition reimbursement supplied by your employer? Ask 
yourself what motivates you. Is it working from home? If so, then find a different  type of job that  you can do from 
home and enjoy. If you thrive on intellectual challenge in your work, take a class. If it  is the travel you enjoy with 
your MSL job, can you travel and enhance your work at the same time? If you like the autonomy of the job, have 
you thought about starting your own company? Even though your title may stay the same, as a MSL, you can 
work on many internal projects while keeping your traditional work flowing. What type of internal work will 
make you engaged and interested? Some MSLs have made their entire careers out of being a MSL, and there is 
absolutely nothing wrong with being a career MSL. The challenge is finding out what makes you personally tick 
and maximizing that  part  or facet  of your work while minimizing or eliminating the work you don’t  enjoy 
performing.
The Real World: An Interview with a Working MSL - Ernie Pitting, RPh, MS, 
PharmD candidate
Ernie is currently a MSL covering the central United States for a small pharmaceutical company. He began as a 
registered pharmacist working in various positions, including decentralized hospital pharmacy, community 
pharmacy, and various roles within industry. He has worked in market research, and spent many years working 
his way up through the ranks of the pharmaceutical sales realm, both in general and specialty sales. He holds a 
BS in pharmacy, and a Master’s in Science from the University of Wisconsin in Pharmaceutical Marketing, and is 
currently working on his PharmD.
How long have you been a MSL?
Five years. I have observed many colleagues move on to different  companies. In conversations with my former 
colleagues I have discovered each pharmaceutical company utilizes their MSLs in very different ways. In fact, 
even their titles within each company differ.
You came from a sales position. How has sales helped you become a MSL?
There are multiple aspects that are helpful. It  is beneficial because: 1. Being a representative helps you understand 
the foundation and basic work of the company and the industry (sales, marketing, research and development, 
medical affairs, etc.). 2. More specifically, it helped me to understand how to make presentations one on one in a 
professional, yet  conversational manner and how to tailor that presentation as you move through it, based on your 
reading of your audience of one. 3. It  taught  me how to be comfortable in front  of physicians and gain access to 
them, and not think of them as MDeities. Some pharmacists are unfortunately not comfortable in front of 
physicians. 4. I have come to appreciate that  the landscape of knowledge and interest is vastly different  between 
community and academic physician practices. 5. I gained an invaluable working knowledge of the important 
interplay between field-based staff and home based staff (as I say, “in house and out  house people”), and how to 
get things done. For example, how to gain agreement  between various factions to get a pilot  study done. How to 
build a consortium of financial support to secure funding for an important  educational endeavor, as another 
example. It  is very important  to know how companies in general and how your specific company gets things 
done, and how it serves its physician and patient customers.
While MSLs are definitely scientific and fair balanced in their focus, we do so within the workings for a 
proprietary company. As such, I think in the MSL role, it  is important  to understand the role of pharmaceutical 
representatives. That doesn’t  mean you become a salesperson as a MSL. However, you can empathize and work 
with them because you understand their needs better. While the roles that MSLs and sales representatives execute 
are quite separate, they are each best served by engaging in some degree of collaboration.
What are your professional rewards from the job?
I am rewarded by my collegial relationships with high level thought  leaders in different therapeutic areas. I have 
the luxury of knowing a little about a lot  and talking to thought leaders at a high level. That is cool for me. I also 
love connecting the dots - from management of patients, to thinking about different therapeutic areas, to pilot 
studies that may progress to bigger National Institutes of Health (NIH) funded studies down the road. It  is fun to 
have conversations with physicians about  data. I have a great  passion for the disease states I work in and enjoy my 
conversations. The firm I have been with has helped me develop a passion for my therapeutic area. The face 
recognition I have with thought leaders outside of my immediate geography is rewarding as well. I am on a first 
name basis with many of these national experts. That is really cool and one of the rewards of my work.
Tell us about your educational background and how it has helped you as a MSL.
My perception is that the standard for MSLs will be a doctorate degree. My newfound interest  in my PharmD 
program is that nearly every therapeutic area I’ve reviewed for school, I have found some pearl or interesting 
piece of information that  I’ve been able to put into my own therapeutic area as a MSL. It has helped me become 
better at  what I do - I am a better MSL through this educational process. I can talk at  an even higher level in basic 
and clinical science. For example, I was at  Mayo talking to a group in a scientific arena that was cutting edge. 
Their more tangential issues are now quite understandable. As such, being that drug information expert with my 
thought  leaders has been great. I’m getting more current information than some of my colleagues who obviously 
went to school several years ago. This too is very helpful.
What do you like best and least about the MSL job?
The best part  is professional fulfillment as I mentioned. It has given me a better pay scale than I’ve never had. I 
am frankly paid well for work I love to do. I have found where I’m supposed to be in life!
The downside of the job is the world that I work in is always ‘gray,’ unlike true pure research and development, or 
pure marketing. It  can be frustrating at  times as we are pulled and pushed in different  directions. It is important to 
always remember that you are hired because you are a professional, and as such, are paid to make those judgment 
calls based on your professional background. I’m now covering 13 states, so the geography has been a challenge. 
It  is really cool to go to some other major medical centers, but travel isn’t  as glamorous as it  used to be. Another 
challenge is that some clinicians don’t value MSLs. Not  all clinicians find the same value in the data or in 
information you can share. Corporate politics are a challenge at times as well. Achieving a work/life/school 
balance has also been a challenge. For example, working at home can become obsessive; there is always 
something else to be done. Medical conferences are on weekends. The impact of all this travel can have negative 
implications for significant  others. Turnover and change is challenging for others, whereas I have not yet had this 
as an issue.
What advice would you give to a pharmacist interested in this role?
Advise them that  working for industry is not a bad thing. We all work for money, but  working for a company can 
stimulate science. Perspective is really important; everyone is selling something! The challenge of working as a 
MSL is that  you have to be really self motivated. If you need someone to help you show up on time or if you need 
to work in a more personal, every day community-ish setting versus a virtual community; this may not be the role 
for you. If you are a self-starter and like freedom and variety and can manage the balance of travel and life, as 
well as work in a more virtual working environment, this can be a marvelous position.
It  takes at  least  an entire year before the MSL job clicks. You need to remain in a job for at least one year to figure 
out whether or not  you like it. It  takes awhile to get  it  all together, so you do need to give it a chance. You have to 
be willing to motivate yourself enough to keep learning. To not  know the answer to something once is acceptable, 
but not twice. This isn’t  emergency medicine, but one does need to be self-motivated in order to perfect  the work 
and the craft of being a MSL.
Take advantage of all the resources you can to expand your knowledge. I don’t  think we had the opportunity to 
pull apart  studies in pharmacy school. We also didn’t  get  enough training in developing a question for research, 
putting that protocol together and then doing the work. After that there is writing of an abstract, getting it  accepted 
at  a meeting, developing a poster, and finally writing the manuscript. It is very important  to understand the world 
of published medical science. The world of medicine is driven by data - to understand and value the literature is 
key. Using textbooks and professors does NOT mean one is reading the primary literature.
In the current environment, it  is interesting to appreciate the evolving world of medicine. Academicians have 
become even more strapped for time due to training and clinical responsibilities, as well as traveling and 
speaking. They simply have even less time to read the literature. This has become a huge opportunity for MSLs as 
they can provide updates for the academicians. I see this as an ongoing trend. Even national thought  leaders don’t 
have the time to read their journals.
The other challenge is technology related. Technology is everywhere. It  has become a little too easy for people to 
communicate. As such, managing the multiple streams of communication is becoming a challenge for all of us. In 
addition, everyone expects immediate access, and unfortunately that’s not always possible when working in the 
field.
You mentioned the variety of work within the scope of the title “Medical Science Liaison.”
Yes, I think it’s changing and evolving. Interview with many companies and ask if you can talk with a MSL 
currently on the team to describe the job. Every company does the job differently. Some companies have their 
MSLs focus more on research, or more education, or more presentations. Some companies have their MSLs do all 
of these functions. I have also come to appreciate having “tough skin” in this work. Don’t take comments too 
personally. Working in sales helped me immensely with this issue. Sometime someone will take his or her bad day 
out on you. It is important that you remain confident in what you are doing--one must stay resilient.
I think it’s a really great role for someone that  is independent. If you like knowing a little about  a lot, if you like 
working with professionals in different arenas (sales, marketing, academia) and don’t  mind the travel or the lack 
of an office family, it’s a cool role. The industry is really not the devil incarnate. It is important  to have 
perspective on the values that the industry brings at large.
When I was a sales representative many years ago, I would spend 20 to 30 minutes discussing a new article from 
a journal with a physician. However, the world of medicine has drastically changed since then. Sales 
representatives may get  only get  10 seconds of sound bite selling. So now the old representative’s role is the new 
MSLs role. Many years ago, Upjohn and Lilly employed only pharmacists as sales representatives. Now it’s been 
elevated to the MSL role.
Just another point, physicians don’t like turnover. They do like to develop relationships with colleagues in 
industry. In addition, many doctors love to see PharmD’s who understand clinical practice. They want clinical 
experience and relevant patient  practice conversations based upon the literature. Simply put, I think this is a 
fascinating role for pharmacists out there that wish to challenge themselves with work that is not black or white.
